Skip to main content

Table 1 Patient demographics

From: Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy

Characteristic Low risk (n = 31) High risk (n = 44) Total (n = 75)
Age at surgery
 Median years (range) 61 (45–76) 64 (44–77) 63 (44–77)
PSA at diagnosis
 Median No. (range) 6.6 (4–16.7) 10 (1.8–140) 8.5 (1.8–140)
PSA at day biobanked
 Median No. (range) 0.1 (0–1.7) 0.1 (0–16.6) 0.11 (0–16.6)
No. Gleason score (%)
 6 3 (10) 0 3 (4)
 7 28 (90) 19 (43) 47 (63)
 8 0 9 (20) 9 (12)
 9 0 16 (36) 16 (21)
No. pathological tumour stage (%)
 ≤ pT2 23 (74) 3 (7) 26 (35)
 pT3a 8 (26) 22 (50) 30 (40)
 pT3b 0 18 (41) 18 (24)
 pT4 0 1 (2) 1 (1)
No. margin status (%)
 Positive 11 (35) 30 (68) 41 (55)
 Negative 20 (65) 14 (32) 34 (45)
No. salvage therapy (%)
 Radiation 23 (74) 33 (75) 56 (75)
 Hormone 16 (52) 34 (77) 50 (67)